Laddar...
Oncolytic virotherapy using herpes simplex virus: how far have we come?
Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. The human pathogen herpes simplex virus (HSV) has proven particularly amenable for use in oncolytic virotherapy. The relative safety of HSV coupled with extensive knowledge on how HSV interacts wit...
Sparad:
| I publikationen: | Oncolytic Virother |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918397/ https://ncbi.nlm.nih.gov/pubmed/27512683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66086 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|